...
首页> 外文期刊>Current therapeutic research, clinical and experimental. >Antihypertensive Effect of Zofenopril Plus Hydrochlorothiazide Versus Zofenopril Monotherapy in Patients with Essential Hypertension According to Their Cardiovascular Risk Level: A Post Hoc Analysis
【24h】

Antihypertensive Effect of Zofenopril Plus Hydrochlorothiazide Versus Zofenopril Monotherapy in Patients with Essential Hypertension According to Their Cardiovascular Risk Level: A Post Hoc Analysis

机译:佐非诺普尔加氢氯噻嗪对佐芬普利单药治疗对高血压的心血管风险水平的降压作用:事后分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: International guidelines recommend the use of angiotensin-converting enzyme inhibitors, possibly in combination with other antihypertensive drugs, to treat hypertension with associated risk factors. OBJECTIVE: The aim of this study was to compare the antihypertensive effect of the combination of zofenopril plus hydrochlorothiazide versus zofenopril monotherapy in patients with essential hypertension, according to their cardiovascular risk level.
机译:背景:国际指南建议使用血管紧张素转换酶抑制剂(可能与其他降压药联合使用)治疗具有相关危险因素的高血压。目的:本研究旨在比较佐芬普利联合氢氯噻嗪与佐芬普利单药联合治疗原发性高血压患者的降压效果,根据其心血管风险水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号